200 related articles for article (PubMed ID: 12111781)
1. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
Hasselbalch HC; Clausen NT; Jensen BA
Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
[TBL] [Abstract][Full Text] [Related]
2. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach.
Rodríguez JN; Martino ML; Diéguez JC; Prados D
Haematologica; 1998 Jul; 83(7):616-21. PubMed ID: 9718866
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature.
Cervantes F; Alvarez-Larrán A; Hernández-Boluda JC; Sureda A; Torrebadell M; Montserrat E
Br J Haematol; 2004 Nov; 127(4):399-403. PubMed ID: 15521916
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin treatment of idiopathic myelofibrosis.
Aloe Spiriti M; Latagliata R; Avvisati G; Battistel V; Montefusco E; Spadea A; Petti MC
Haematologica; 1993; 78(6):371-3. PubMed ID: 8175031
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.
Tsiara SN; Chaidos A; Bourantas LK; Kapsali HD; Bourantas KL
Acta Haematol; 2007; 117(3):156-61. PubMed ID: 17159338
[TBL] [Abstract][Full Text] [Related]
6. Danazol treatment of idiopathic myelofibrosis with severe anemia.
Cervantes F; Hernández-Boluda JC; Alvarez A; Nadal E; Montserrat E
Haematologica; 2000 Jun; 85(6):595-9. PubMed ID: 10870115
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
11. Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Chawla B; Iqbal FM; Chawla MS
Compr Ther; 2009; 35(3-4):199-203. PubMed ID: 20043618
[TBL] [Abstract][Full Text] [Related]
12. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients.
Cervantes F; Alvarez-Larrán A; Domingo A; Arellano-Rodrigo E; Montserrat E
Br J Haematol; 2005 Jun; 129(6):771-5. PubMed ID: 15953003
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
16. Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases.
Lévy V; Bourgarit A; Delmer A; Legrand O; Baudard M; Rio B; Zittoun R
Am J Hematol; 1996 Dec; 53(4):239-41. PubMed ID: 8948661
[TBL] [Abstract][Full Text] [Related]
17. Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes.
Musto P; Falcone A; Sanpaolo G; Bodenizza C
Leuk Res; 2006 Apr; 30(4):385-8. PubMed ID: 16219350
[TBL] [Abstract][Full Text] [Related]
18. [Use of human recombinant erythropoietin in children with cancer].
Guyot D; Margueritte G
Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
20. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
Mittelman M
Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
